- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Hong Kong Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
2
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$12.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$14.92
7D
1.2%
1Y
86.7%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
New
2161
HK$2.99
7D
0%
1Y
75.9%